β-adrenergic receptor density and adenylate cyclase activity in lead-exposed rat brain after cessation of lead exposure

Archives of Toxicology

Volumn 79, Issue 1, 2005, Pages 1-6

  Chang, Huoy Rou ^a   Tsao, Der An ^b   Yu, Hsin Su ^c   Ho, Chi Kung ^d  

^a I SHOU UNIVERSITY   (Taiwan)

^b FOOYIN UNIVERSITY   (Taiwan)

^c TAIWAN UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

adrenoceptor; Adenylate cyclase activity; Brain; Lead

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CYANOPINDOLOL I 125; CYCLIC AMP; LEAD; RADIOLIGAND;

ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BRAIN; CONTROLLED STUDY; DRUG EXPOSURE; DRUG WITHDRAWAL; ENZYME ACTIVITY; LEAD BLOOD LEVEL; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RAT STRAIN;

ADENYLATE CYCLASE; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BRAIN; CYCLIC AMP; DISEASE MODELS, ANIMAL; IODOCYANOPINDOLOL; LEAD; LEAD POISONING; MALE; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; TIME FACTORS; TISSUE DISTRIBUTION;

ANIMALIA; RATTUS NORVEGICUS;

EID: 12944302105     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-004-0605-9     Document Type: Article

References (34)

1. Baker EL, Feldman RG, White RA (1984) Occupational lead neurotoxicity: a behavioral and electrophysiological evaluation. Br J Ind Med 41:352-361
2. Baker EL, Feldman RG, White RA (1985) Occupational lead in neurotoxicity: improvement in behavioral effects after reduction of exposure. Br J Ind Med 42:507-516
3. Bennett WM (1985) Lead nephrophathy. Kidney Int 28:212-220
4. Booze RM, Crisostomo EA, Davis JN (1989) Species differences in the localization and number of CNS beta adrenergic receptors: rat versus guinea pig. J Pharmacol Exp Ther 249:911-920
5. Bornschein R, Rearson D, Reiter L (1980) Behavioral effects of moderate lead exposure in children and animal models. Part 2, animal studies. CRC Crit Rev Toxicol 8:101-152
6. Brown BL, Albano JDM, Ekins RP, Sgherzi AM (1971) A simple and sensitive saturation assay method for the measurement of adenosine 3′:5′- cyclic monophosphate. Biochem J 121:561-562
7. Chang HR, Chen SS, Chen TJ, Ho CK, Chiang HC, Yu HS (1996) Lymphocyte β2-adrenergic receptors and plasma catecholamine levels in lead-exposed workers. Toxicol Appl Pharmacol 139:1-5
8. Chisolm JJ, Barrett MB, Harrison HV (1975) Indicators of internal dose of lead in relation to derangement in heme synthesis. Johns Hopkins Med J 137:6-12
9. De Blase A (1989) Advances on beta-adrenergic receptors molecular structure and function regulation. Am J Hypertens 2:252s-256s
10. Dibner M, Molinoff P (1979) Agonist-induced changes in beta-adrenergic receptor density and receptor-mediated responsiveness in slices of rat cerebral cortex. J Pharmacol Exp Ther 210:433-439
11. Feldman RD, Limbird LE, Nadeau J, Fitzgerald GA, Robertson D, Wood AJJ (1983) Dynamic regulation of leukocyte beta adrenergic receptor-agonist interactions by physiological changes in circulating catecholamines. J Clin Invest 72:164-170
12. Forni A, Cambiaghi G, Secchi GC (1976) Initial occupational exposure to lead. Arch Environ Health 31:73-78
13. Ghosh S, Chatterjee AK, Malaya G (1992) Impact of lead toxicity on brain metabolisms of nucleic acid and catecholamine in protein malnourished rats. J Nutr Sci Vitaminol (Tokyo) 38:451-462
14. Jason KM, Kellog CK (1980) Behavioral neurotoxicity of lead. In: Singhal RL, Thomas JA (eds) Lead toxicity. Urban and Schwarzenberg, Baltimore, pp 241-272
15. Kehoe RA (1969) Toxicological appraisal of lead in relation to the tolerable concentration in the ambient air. J Air Pollut Control Assoc 19:690-700
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
17. Mantere P, Hanninen H, Hernberg S, Luukkonen R (1984) A prospective follow-up study on psychological effects in workers exposed to low levels of lead. Scand J Work Environ Health 10:43-50
18. Mcintosh MJ, Meredith PA, Moore MR, Goldberg A (1989) Action of lead on neurotransmission in rats. Xenobiotica 19:101-113
19. Michaelson AE (1980) An appraisal of rodent studies on the behavioral toxicity of lead: the role of nutritional status. In: Singhal RL, Thomas JA (eds) Lead toxicity. Urban and Schwarzenberg, Baltimore, pp 301-366
20. Murata K, Araki S (1991) Autonomic nervous system dysfunction in workers exposed to lead, zinc, and copper in relation to peripheral nerve conduction: a study of R-R interval variability. Am J Ind Med 20:663-671
21. Perelman S, Hertz-Pannier L, Hassan M (1993) Lead encephalopathy mimicking a cerebellar tumor. Acta Paediatr 82:423-425
22. Robinowitz MB, Wetherill GW, Kopple JD (1976) Kinetic analysis of lead metabolism in healthy humans. J Clin Invest 58:260-270
23. Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 51:660-672
24. Severson JA (1984) Neurotransmitter receptors and aging. J Am Geriatr Soc 32:24
25. Shukla A, Agarwal KN, Shukla GS (1990) Effect of latent iron deficiency on the levels of iron, calcium, zinc, copper, manganese, cadmium and lead in liver, kidney and spleen of growing rats. Experientia 46:751-752
26. Stokinger HE (1981) The metals. In: Clayton GK, Clyton FE (eds) Patty's industrial hygiene and toxicology. Wiley Interscience, New York, pp 1687-1728
27. Suga RS, Fischinger AJ, Knoch FW (1981) Establishment of normal values in adults for zinc protoporphyrin (ZPP) using a hematofluorometer: correlation with normal blood lead values. Am Ind Hyg Assoc J 42:637-642
28. Sugrue MF (1983) Chronic antidepressant therapy and associated changes in central mono-aminergic receptor functioning. Pharmacol Ther 21:1-33
29. Tsao DA, Yu HS, Cheng JT, Ho CK, Chang HR (2000a) The change of β-adrenergic system in lead-induced hypertension. Toxicol Appl Pharmacol 164:127-133
30. Tsao DA, Yu HS, Cheng JT, Ho CK, Chang HR (2000b) Alterations in β-adrenergic receptor density and adenylate cyclase activity in the rat brain treated chronically with lead. Toxicology 146:93-99
31. U'Prichard D, Enna SJ (1979) In vitro modulation of CNS β-receptor number by antidepressants and β-agonists. Eur J Pharmacol 59:297-301
32. Wagner HR, Davis JN (1979) β-adrenergic receptor regulation by agonists and membrane depolarization in rat brain slices. Proc Natl Acad Sci U S A 76:2057-2061
33. Wiley J, Henretig F, Foster R (1995) Status epilepticus and severe neurologic impairment from lead encephalopathy, November 1994 (abstract 114). J Toxicol Clin Toxicol 33:529-530
34. Winneke G (1986) Animal studies. In: Lansdown R, Yule W (eds) The lead debate: the environment, toxicology and child health. Croom Helm, London, pp 217-234